These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 39003680)

  • 1. Trametinib for a child with refractory Rosai-Dorfman-Destombes disease harboring a novel somatic mutation in MAP2K1.
    Taneyama Y; Morimoto A; Ochiai H; Ando K; Kakuda H; Naruke Y; Yokoi S
    Int J Hematol; 2024 Oct; 120(4):520-524. PubMed ID: 39003680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case of recurrent histiocytic sarcoma with MAP2K1 pathogenic variant treated with the MEK inhibitor trametinib.
    Kumamoto T; Aoki Y; Sonoda T; Yamanishi M; Arakawa A; Sugiyama M; Shirakawa N; Ishimaru S; Saito Y; Maeshima A; Maeda M; Ogawa C
    Int J Hematol; 2019 Feb; 109(2):228-232. PubMed ID: 30361829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosai-Dorfman-Destombes disease - histiocytic disorder with inflammatory manifestation.
    Adam Z; Adamová Z; Pour L; Řehák Z; Koukalová R; Král Z
    Klin Onkol; 2022; 35(4):262-170. PubMed ID: 35989082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease.
    Garces S; Medeiros LJ; Patel KP; Li S; Pina-Oviedo S; Li J; Garces JC; Khoury JD; Yin CC
    Mod Pathol; 2017 Oct; 30(10):1367-1377. PubMed ID: 28664935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Drug Regimen-Refractory Rosai-Dorfman-Destombes Disease Mimicking Relapsing Polychondritis Successfully Treated with Cobimetinib.
    López-Aldabe K; Escrihuela-Vidal F; Tuells-Morales M; Llobera-Ris C; Bauer-Alonso A; Cortes-Romera M; Gràcia-Sànchez L; Tormo-Ratera M; Juanola Roura X; Penin-Mosquera RM; Corbella X; Solanich X
    Eur J Case Rep Intern Med; 2022; 9(2):003076. PubMed ID: 35265540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trametinib in the treatment of multiple malignancies harboring MEK1 mutations.
    Lian T; Li C; Wang H
    Cancer Treat Rev; 2019 Dec; 81():101907. PubMed ID: 31715422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosai-Dorfman Disease between Proliferation and Neoplasia.
    Elbaz Younes I; Sokol L; Zhang L
    Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
    Abla O; Jacobsen E; Picarsic J; Krenova Z; Jaffe R; Emile JF; Durham BH; Braier J; Charlotte F; Donadieu J; Cohen-Aubart F; Rodriguez-Galindo C; Allen C; Whitlock JA; Weitzman S; McClain KL; Haroche J; Diamond EL
    Blood; 2018 Jun; 131(26):2877-2890. PubMed ID: 29720485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A meta-analysis of cases of Rosai Dorfman disease reported on the African continent and a description of two cases from a tertiary academic hospital in Johannesburg, South Africa.
    Laudin GE; Lakha AB; Dullabh N; Mohanlal R; Jassat R; Waja MF; Philip V
    Pan Afr Med J; 2023; 45():130. PubMed ID: 37790150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature.
    McIntire PJ; Kilic AI; Chen HH; Atieh M; Wojcik EM; Pambuccian SE
    J Am Soc Cytopathol; 2019; 8(4):190-205. PubMed ID: 31272602
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Rosai-Dorfman-Destombes disease with a misleading laryngeal presentation].
    Fiani DJ; Émile JF; Istier L; Boutin AB; Tychyj C; Benzerdjeb N; Donzel M; Balme B; Traverse-Glehen A; Fontaine J
    Ann Pathol; 2022 Nov; 42(6):475-480. PubMed ID: 36038429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary intraosseous Rosai-Dorfman disease: a clinicopathological analysis of fourteen cases].
    Dong RF; Gong LH; Zhang W; Li L; Sun XQ; Zhang M; Ding Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Sep; 49(9):904-909. PubMed ID: 32892555
    [No Abstract]   [Full Text] [Related]  

  • 16. KRAS 117N positive Rosai-Dorfman disease with atypical features.
    Jafri ZA; Reddy SP; Cassarino DS
    J Cutan Pathol; 2021 Jan; 48(1):147-150. PubMed ID: 32974961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erdheim-Chester disease with Rosai-Dorfman-like lesions: treatment with methotrexate, anakinra and upadacitinib.
    Portegys J; Heidemeier A; Rosenwald A; Gernert M; Fröhlich M; Hueper S; Strunz PP; Rasche L; Schmalzing M
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36693681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trametinib in Histiocytic Sarcoma with an Activating MAP2K1 (MEK1) Mutation.
    Gounder MM; Solit DB; Tap WD
    N Engl J Med; 2018 May; 378(20):1945-1947. PubMed ID: 29768143
    [No Abstract]   [Full Text] [Related]  

  • 19. BRAF mutation leading to central nervous system rosai-dorfman disease.
    Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
    Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Histiocytosis of Rosai-Dorfman-Destombes extranodal of the jawbone: Report of a case and review of the literature].
    Vaquier L; Abitbol C; Emile JF; Dossier A; Guyard A; Hourseau M
    Ann Pathol; 2022 Apr; 42(3):264-268. PubMed ID: 35033363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.